Midway Specialty Care Center · Temple Terrace, FL
PrEP in Temple Terrace, Florida
Board-certified infectious disease specialists prescribing and monitoring PrEP — daily pills or long-acting injectable — to protect you from HIV.
PrEP in Temple Terrace
HIV Prevention That Works — Close to Home
PrEP (pre-exposure prophylaxis) is a highly effective medication strategy for HIV-negative individuals who are at risk of exposure. When taken as prescribed, daily oral PrEP reduces the risk of getting HIV from sex by up to 99% — and injectable PrEP offers the same protection without a daily pill.
At Midway Specialty Care Center in Temple Terrace, our infectious disease specialists have deep experience with both oral and injectable PrEP options. We handle the initial evaluation, prescription, and all required follow-up lab monitoring — so your protection stays current and effective.
Whether you're starting PrEP for the first time, switching options, or looking to transfer your care to a specialist, we're here to help.
What PrEP Care at Midway Includes
Comprehensive PrEP care — from your first evaluation through long-term monitoring.
PrEP Evaluation & Prescription
Your provider will review your health history, assess your risk factors, and confirm you're HIV-negative before prescribing PrEP. We'll discuss both daily oral options (Truvada and Descovy) and long-acting injectable PrEP (Apretude) so you can choose the approach that fits your life.
Daily Oral PrEP (Truvada / Descovy)
Truvada and Descovy are FDA-approved once-daily pills that provide up to 99% protection against HIV when taken consistently. Your provider will help you choose between them based on your kidney function, bone health, and specific risk profile. Refills and medication assistance are handled through our 340B program.
Long-Acting Injectable PrEP (Apretude)
Apretude (cabotegravir injection) is a long-acting PrEP option administered in-office every two months — no daily pills needed. For patients who struggle with daily adherence or prefer a more discreet option, injectable PrEP offers the same high level of HIV protection on a schedule that works better for them.
Required Lab Monitoring
PrEP requires regular lab work to ensure it remains safe and effective. We monitor for HIV status, kidney function, STIs, and hepatitis B every three months — catching any issues early and keeping your prescription current. Our team coordinates all required testing and reviews results with you at each visit.
Medication Assistance & 340B Access
PrEP medications can be costly without the right coverage. As a federally qualified 340B nonprofit clinic, we can significantly reduce medication costs for eligible patients. Our team also assists with insurance navigation and manufacturer patient assistance programs — ensuring cost is never a reason to go without protection.
Your Care Team in Temple Terrace
Board-certified infectious disease specialists experienced in PrEP and HIV prevention.
Dr. Moti Ramgopal
MD, FACP, FIDSA, Chairman
Dr. Moti Ramgopal is the Founder and Director of Midway Immunology and Research Center and the Founder/Chairman of the not-for-profit Midway Specialty Care Center in Florida and Guyana. Additionally, he is a Consultant Physician/Director of Associates in Infectious Diseases and a Clinical Professor at Florida State University College of Medicine. He also serves as an HIV Consultant for the Ministry of Health in the Turks and Caicos Islands. Dr. Ramgopal is certified by the American Board of Internal Medicine and Infectious Diseases with expertise in clinical research and the rapid implementation of novel, cutting-edge treatments for over 25 years. As Principal Investigator at Midway Immunology and Research Center, he has overseen 300+ clinical trials, with his research published in peer-reviewed journals and presented at various national and international conferences. His work has been published in the Lancet, Journal of Clinical Infectious Diseases, and Journal of Acquired Immune Deficiency Syndromes. Additionally, he has presented research at the 2023 International AIDS Society Conference on HIV Science and the Conference on Retroviruses and Opportunistic Infections. As a Consulting Physician, he is affiliated with multiple hospitals within the Treasure Coast area. His team provides comprehensive services such as wound care and outpatient IV antibiotics (OPAT). In addition, he provides opportunities for patients to transfer from inpatient care to outpatient medicine through the availability of an infusion center. Through Midway Specialty Care Center, Dr. Ramgopal and his team embrace the initiative of ending the HIV and HCV epidemics by 2030 in critical communities throughout Florida. To expand the organization's reach, he established two clinics in Georgetown, Guyana, providing the community with new opportunities and access to various clinical and laboratory services. Due to his experiences and efforts, US News and World Reports recognized Dr. Ramgopal as a top Infectious Disease Doctor. Dr. Ramgopal received his medical degree from the University of the West Indies Faculty of Medical Sciences and completed a Residency in Internal Medicine at Beaumont Hospital in Michigan. He then completed a Fellowship in Infectious Diseases at Jackson Memorial and the University of Miami School of Medicine. Dr. Ramgopal is passionate about integrating healthcare from developed to underdeveloped communities, especially in the Caribbean, by introducing advancing technologies, clinical research, and trials. Originally from Guyana and previously the Medical Director of PEPFAR in Guyana, he opened a clinic in Georgetown, Guyana, in 2019 where he actively gives back to the community he grew up in. In addition, Dr. Ramgopal continues to explore opportunities to reach high-risk groups nationally and internationally by providing opportunities to practice medicine, educational training, and consultation services.
Dr. Moti Ramgopal
MD, FACP, FIDSA, Chairman
Dr. Moti Ramgopal is the Founder and Director of Midway Immunology and Research Center and the Founder/Chairman of the not-for-profit Midway Specialty Care Center in Florida and Guyana. Additionally, he is a Consultant Physician/Director of Associates in Infectious Diseases and a Clinical Professor at Florida State University College of Medicine. He also serves as an HIV Consultant for the Ministry of Health in the Turks and Caicos Islands. Dr. Ramgopal is certified by the American Board of Internal Medicine and Infectious Diseases with expertise in clinical research and the rapid implementation of novel, cutting-edge treatments for over 25 years. As Principal Investigator at Midway Immunology and Research Center, he has overseen 300+ clinical trials, with his research published in peer-reviewed journals and presented at various national and international conferences. His work has been published in the Lancet, Journal of Clinical Infectious Diseases, and Journal of Acquired Immune Deficiency Syndromes. Additionally, he has presented research at the 2023 International AIDS Society Conference on HIV Science and the Conference on Retroviruses and Opportunistic Infections. As a Consulting Physician, he is affiliated with multiple hospitals within the Treasure Coast area. His team provides comprehensive services such as wound care and outpatient IV antibiotics (OPAT). In addition, he provides opportunities for patients to transfer from inpatient care to outpatient medicine through the availability of an infusion center. Through Midway Specialty Care Center, Dr. Ramgopal and his team embrace the initiative of ending the HIV and HCV epidemics by 2030 in critical communities throughout Florida. To expand the organization's reach, he established two clinics in Georgetown, Guyana, providing the community with new opportunities and access to various clinical and laboratory services. Due to his experiences and efforts, US News and World Reports recognized Dr. Ramgopal as a top Infectious Disease Doctor. Dr. Ramgopal received his medical degree from the University of the West Indies Faculty of Medical Sciences and completed a Residency in Internal Medicine at Beaumont Hospital in Michigan. He then completed a Fellowship in Infectious Diseases at Jackson Memorial and the University of Miami School of Medicine. Dr. Ramgopal is passionate about integrating healthcare from developed to underdeveloped communities, especially in the Caribbean, by introducing advancing technologies, clinical research, and trials. Originally from Guyana and previously the Medical Director of PEPFAR in Guyana, he opened a clinic in Georgetown, Guyana, in 2019 where he actively gives back to the community he grew up in. In addition, Dr. Ramgopal continues to explore opportunities to reach high-risk groups nationally and internationally by providing opportunities to practice medicine, educational training, and consultation services.
View Full Profile →
Rodrigo Sabec
APRN
Rodrigo Sabec is originally from Brazil but relocated and settled in the Tampa area. He received his Master's degree in Sciences of Nursing from South University in Tampa, Florida, and he is Board Certified by The American Academy of Nurse Practitioners National Certification Board, Inc. as a Family Nurse Practitioner. He has a focused interest in HIV treatment, transgender care and PrEP and enjoys spending time with Ginger and Ella (his dogs) and loved ones.
Rodrigo Sabec
APRN
Rodrigo Sabec is originally from Brazil but relocated and settled in the Tampa area. He received his Master's degree in Sciences of Nursing from South University in Tampa, Florida, and he is Board Certified by The American Academy of Nurse Practitioners National Certification Board, Inc. as a Family Nurse Practitioner. He has a focused interest in HIV treatment, transgender care and PrEP and enjoys spending time with Ginger and Ella (his dogs) and loved ones.
View Full Profile →
Who Should Consider PrEP
PrEP is for anyone who is HIV-negative and at risk of exposure — regardless of identity or relationship status.
LGBTQ+ Individuals
Gay, bisexual, and other men who have sex with men represent the majority of PrEP users. We provide affirming, knowledgeable care in a welcoming environment where you can discuss your needs openly and without judgment.
Partners of HIV-Positive Individuals
If your partner is HIV-positive — even if they are undetectable on treatment — PrEP adds an additional layer of protection. We work with both partners and provide coordinated care when needed.
Anyone with Multiple or Unknown-Status Partners
If you have sexual partners whose HIV status is unknown or who may be at risk, PrEP significantly reduces your risk of acquiring HIV — regardless of your gender or sexual orientation.
Transferring or Restarting PrEP
Already on PrEP and looking for a new provider? Taking a break and ready to restart? We make it straightforward to continue your current regimen or explore whether a different option — like injectable PrEP — might be a better fit.
What to Expect at Your First PrEP Visit
Getting started on PrEP is straightforward. Here's what the process looks like.
Schedule Your Appointment
Call our Temple Terrace office at (813) 733-8224 or submit the request form. Our staff will schedule a new patient PrEP consultation and let you know what to bring, including any records from a previous provider if applicable.
Baseline Evaluation & Lab Work
Before starting PrEP, you'll receive a full baseline HIV test, kidney function panel, hepatitis B and C screening, and STI testing. This establishes your starting point and confirms you're a good candidate for PrEP. Results are typically available within a few days.
Choose Your PrEP Option & Start
Once labs are reviewed, your provider will discuss oral and injectable options and issue your prescription or schedule your first injection. We'll also go over how PrEP works, what to do if you miss a dose, and when to come back for follow-up.
Ongoing Monitoring Every 3 Months
PrEP requires a follow-up visit every three months to repeat HIV testing, check kidney function, screen for STIs, and renew your prescription. These appointments are quick and our team makes them easy to fit into a busy schedule. Injectable PrEP patients receive their next injection at each visit.
Book an Appointment
Temple Terrace · PrEP & HIV Prevention
Use our secure online scheduler to choose a convenient date and time for your PrEP consultation.
Book Appointment OnlineOr call (813) 733-8224
Contact Us
11454 North 53rd St
Temple Terrace, FL 33617
Clinic Fax
(813) 733-8228
Hours of Operation
New Patient Paperwork
After your appointment is confirmed, you'll receive a link to complete your intake forms online before your visit — from any device, no printing required.
Prefer Paper?
Download and print the forms below if you'd like to complete them by hand before your visit.
Patient Reviews
“I admire your work and commitment to being a healer, and am forever grateful. You have aligned yourself as a top professional in the area.”
— Jon M.